Beyond Air (XAIR) Stock Forecast, Price Target & Predictions
XAIR Stock Forecast
Beyond Air stock forecast is as follows: an average price target of $1.00 (represents a 144.02% upside from XAIR’s last price of $0.41) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
XAIR Price Target
The average price target for Beyond Air (XAIR) is $1.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $1.00 to $1.00. This represents a potential 144.02% upside from XAIR's last price of $0.41.
XAIR Analyst Ratings
According to 2 Wall Street analysts, Beyond Air's rating consensus is 'Buy'. The analyst rating breakdown for XAIR stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Beyond Air Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 07, 2024 | Jason Bednar | Piper Sandler | $1.00 | $0.50 | 98.14% | 144.02% |
The latest Beyond Air stock forecast, released on Aug 07, 2024 by Jason Bednar from Piper Sandler, set a price target of $1.00, which represents a 98.14% increase from the stock price at the time of the forecast ($0.50), and a 144.02% increase from XAIR last price ($0.41).
Beyond Air Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $1.00 |
| Last Closing Price | $0.41 | $0.41 | $0.41 |
| Upside/Downside | -100.00% | -100.00% | 144.02% |
In the current month, the average price target of Beyond Air stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Beyond Air's last price of $0.41. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 12, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 07, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 25, 2024 | BTIG | Buy | Neutral | Downgrade |
| Jun 25, 2024 | BTIG | Buy | Reduce | Downgrade |
| Jun 03, 2024 | BTIG | Buy | Buy | Hold |
Beyond Air's last stock rating was published by Piper Sandler on Nov 12, 2024. The company gave XAIR a "Overweight" rating, the same as its previous rate.
Beyond Air Financial Forecast
Beyond Air Revenue Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $239.00K | $59.00K | - | - | - | $145.63K | $148.79K | $349.61K | $229.16K | $85.87K | $314.38K | $645.60K | $627.47K | $7.72M |
| Avg Forecast | $5.29M | $3.81M | $2.91M | $2.05M | $1.36M | $933.26K | $1.03M | $798.00K | $743.20K | $449.20K | $475.97K | $331.50K | $526.00K | $75.00K | $325.00K | $311.00K | $273.67K | $156.67K | $206.67K | $406.67K | $675.00K | $708.33K | $1.06M | $6.63M |
| High Forecast | $5.66M | $4.07M | $3.11M | $2.19M | $1.44M | $952.31K | $1.05M | $853.10K | $743.30K | $458.37K | $793.28K | $354.39K | $562.32K | $75.00K | $325.00K | $311.00K | $273.67K | $156.67K | $206.67K | $406.67K | $675.00K | $708.33K | $1.06M | $6.63M |
| Low Forecast | $4.86M | $3.50M | $2.67M | $1.88M | $1.27M | $914.21K | $1.02M | $733.48K | $743.10K | $440.03K | $198.32K | $304.69K | $483.47K | $75.00K | $325.00K | $311.00K | $273.67K | $156.67K | $206.67K | $406.67K | $675.00K | $708.33K | $1.06M | $6.63M |
| # Analysts | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.18% | - | - | - | 0.47% | 0.54% | 2.23% | 1.11% | 0.21% | 0.47% | 0.91% | 0.59% | 1.17% |
Beyond Air's average Quarter revenue forecast for Dec 23 based on 2 analysts is $449.20K, with a low forecast of $440.03K, and a high forecast of $458.37K. XAIR's average Quarter revenue forecast represents a 87.95% increase compared to the company's last Quarter revenue of $239.00K (Sep 23).
Beyond Air EBITDA Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-17.03M | $-15.88M | $-13.97M | $-6.03M | $-6.52M | $-4.98M | $-5.59M | $-4.90M | $-6.54M | $-7.04M | $-5.03M | $-4.40M | $-1.49M | $7.10M |
| Avg Forecast | $-1.06M | $-761.83K | $-581.68K | $-409.94K | $-271.27K | $-186.65K | $-206.08K | $-159.60K | $-148.64K | $-89.84K | $-95.19K | $-66.30K | $-105.20K | $-15.00K | $-2.64M | $-62.20K | $-54.73K | $-31.33K | $-4.63M | $-81.33K | $-135.00K | $-141.67K | $-2.63M | $-1.32M |
| High Forecast | $-972.99K | $-700.23K | $-534.65K | $-376.79K | $-254.96K | $-182.84K | $-203.04K | $-146.69K | $-148.62K | $-88.01K | $-39.66K | $-60.94K | $-96.69K | $-15.00K | $-2.11M | $-62.20K | $-54.73K | $-31.33K | $-3.70M | $-81.33K | $-135.00K | $-141.67K | $-2.11M | $-1.32M |
| Low Forecast | $-1.13M | $-814.44K | $-621.85K | $-438.25K | $-287.59K | $-190.46K | $-209.12K | $-170.62K | $-148.66K | $-91.67K | $-158.66K | $-70.88K | $-112.46K | $-15.00K | $-3.17M | $-62.20K | $-54.73K | $-31.33K | $-5.55M | $-81.33K | $-135.00K | $-141.67K | $-3.16M | $-1.32M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 178.87% | 239.45% | 132.77% | 402.09% | 2.47% | 80.04% | 102.17% | 156.30% | 1.41% | 86.61% | 37.27% | 31.09% | 0.56% | -5.36% |
4 analysts predict XAIR's average Quarter EBITDA for Jun 19 to be $-2.63M, with a high of $-2.11M and a low of $-3.16M. This is -137.05% lower than Beyond Air's previous annual EBITDA (Mar 19) of $7.10M.
Beyond Air Net Income Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-16.22M | $-14.10M | $-27.12M | $-11.02M | $-6.73M | $-5.27M | $-5.76M | $-5.14M | $-6.73M | $-5.27M | $-3.71M | $-3.75M | $-10.79M | $-7.20M |
| Avg Forecast | $-3.79M | $-4.58M | $-4.93M | $-5.46M | $-6.88M | $-7.23M | $-13.38M | $-14.93M | $-22.33M | $-25.44M | $-22.10M | $-21.99M | $-22.85M | $-12.76M | $-2.73M | $-14.14M | $-14.34M | $-14.00M | $-4.78M | $-18.13M | $-15.61M | $-13.77M | $-2.67M | $11.48M |
| High Forecast | $-3.39M | $-4.10M | $-4.41M | $-4.88M | $-4.70M | $-5.22M | $-11.98M | $-13.36M | $-19.99M | $-23.78M | $-18.81M | $-19.68M | $-20.45M | $-12.76M | $-2.19M | $-14.14M | $-14.34M | $-14.00M | $-3.83M | $-18.13M | $-15.61M | $-13.77M | $-2.14M | $11.48M |
| Low Forecast | $-4.13M | $-4.99M | $-5.38M | $-5.95M | $-8.68M | $-9.24M | $-14.58M | $-16.27M | $-24.34M | $-27.11M | $-24.45M | $-23.96M | $-24.90M | $-12.76M | $-3.28M | $-14.14M | $-14.34M | $-14.00M | $-5.74M | $-18.13M | $-15.61M | $-13.77M | $-3.21M | $11.48M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.73% | 0.64% | 1.19% | 0.86% | 2.46% | 0.37% | 0.40% | 0.37% | 1.41% | 0.29% | 0.24% | 0.27% | 4.04% | -0.63% |
Beyond Air's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. XAIR's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Beyond Air SG&A Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $10.21M | $10.94M | $9.55M | $3.40M | $3.85M | $3.33M | $2.47M | $2.17M | $2.49M | $2.16M | $2.47M | $2.06M | $2.18M | $2.58M |
| Avg Forecast | $55.68M | $40.07M | $30.59M | $21.56M | $14.27M | $9.82M | $10.84M | $8.39M | $7.82M | $4.73M | $5.01M | $3.49M | $5.53M | $788.94K | $3.42M | $3.27M | $2.88M | $1.65M | $2.17M | $4.28M | $7.10M | $7.45M | $943.18K | $69.69M |
| High Forecast | $59.52M | $42.84M | $32.71M | $23.05M | $15.13M | $10.02M | $11.00M | $8.97M | $7.82M | $4.82M | $8.34M | $3.73M | $5.92M | $788.94K | $3.42M | $3.27M | $2.88M | $1.65M | $2.17M | $4.28M | $7.10M | $7.45M | $1.13M | $69.69M |
| Low Forecast | $51.18M | $36.83M | $28.12M | $19.82M | $13.41M | $9.62M | $10.68M | $7.72M | $7.82M | $4.63M | $2.09M | $3.21M | $5.09M | $788.94K | $3.42M | $3.27M | $2.88M | $1.65M | $2.17M | $4.28M | $7.10M | $7.45M | $754.54K | $69.69M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.04% | 3.14% | 1.73% | 4.30% | 1.13% | 1.02% | 0.86% | 1.32% | 1.15% | 0.51% | 0.35% | 0.28% | 2.31% | 0.04% |
Beyond Air's average Quarter SG&A projection for Dec 23 is $4.73M, based on 2 Wall Street analysts, with a range of $4.63M to $4.82M. The forecast indicates a -53.72% fall compared to XAIR last annual SG&A of $10.21M (Sep 23).
Beyond Air EPS Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.51 | $-0.00 | - | $-0.46 | $-0.31 | $-0.24 | $-0.33 | $-0.30 | $-0.41 | $-0.36 | $-0.33 | $-0.35 | $-1.17 | $-0.78 |
| Avg Forecast | $-0.08 | $-0.10 | $-0.10 | $-0.12 | $-0.15 | $-0.15 | $-0.28 | $-0.32 | $-0.47 | $-0.54 | $-0.47 | $-0.47 | $-0.48 | $-0.28 | $-0.21 | $-0.31 | $-0.31 | $-0.30 | $-0.31 | $-0.40 | $-0.34 | $-0.30 | $-0.28 | $0.25 |
| High Forecast | $-0.07 | $-0.09 | $-0.09 | $-0.10 | $-0.10 | $-0.11 | $-0.25 | $-0.28 | $-0.42 | $-0.50 | $-0.40 | $-0.42 | $-0.43 | $-0.28 | $-0.21 | $-0.31 | $-0.31 | $-0.30 | $-0.31 | $-0.40 | $-0.34 | $-0.30 | $-0.28 | $0.25 |
| Low Forecast | $-0.09 | $-0.11 | $-0.11 | $-0.13 | $-0.18 | $-0.20 | $-0.31 | $-0.35 | $-0.52 | $-0.58 | $-0.52 | $-0.51 | $-0.53 | $-0.28 | $-0.21 | $-0.31 | $-0.31 | $-0.30 | $-0.31 | $-0.40 | $-0.34 | $-0.30 | $-0.28 | $0.25 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.09% | 0.00% | - | 1.65% | 1.45% | 0.78% | 1.06% | 0.98% | 1.31% | 0.91% | 0.97% | 1.17% | 4.18% | -3.12% |
According to undefined Wall Street analysts, Beyond Air's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to XAIR previous annual EPS of $NaN (undefined).
Beyond Air Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LUCD | Lucid Diagnostics | $0.81 | $2.50 | 208.64% | Buy |
| TELA | TELA Bio | $2.76 | $8.00 | 189.86% | Buy |
| XAIR | Beyond Air | $0.46 | $1.00 | 117.39% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| DCTH | Delcath Systems | $11.94 | $22.00 | 84.25% | Buy |
| TMDX | TransMedics Group | $65.71 | $116.33 | 77.04% | Buy |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| CTKB | Cytek Biosciences | $6.43 | $8.50 | 32.19% | Buy |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| NARI | Inari Medical | $56.16 | $64.00 | 13.96% | Buy |
| CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
| CLPT | ClearPoint Neuro | $16.34 | $15.00 | -8.20% | Buy |
| RCEL | AVITA Medical | $12.52 | $9.00 | -28.12% | Buy |